Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg

Journal of Artificial Organs

Volumn 11, Issue 2, 2008, Pages 100-103

  Yamada, Naoto ^a   Uchinuma, Eiju ^a   Kuroyanagi, Yoshimitsu ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Allogeneic cultured dermal substitutes; Fibroblast; Skin ulcer

Indexed keywords

ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CULTURED DERMAL SUBSTITUTE; EPITHELIZATION; FEMALE; FOOT ULCER; GRANULATION TISSUE; HUMAN; LEG ULCER; LOWER LEG; MALE; PRIORITY JOURNAL; SKIN ULCER; TREATMENT OUTCOME; WOUND ASSESSMENT; WOUND DRESSING; WOUND HEALING;

AGED; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; LEG ULCER; MALE; MIDDLE AGED; TISSUE ENGINEERING; WOUND HEALING;

EID: 46749139094     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-008-0406-7     Document Type: Article

References (24)

1. Yamada N, Shioya N, Kuroyanagi Y. Evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix as a wound dressing. Scand J Plast Reconstr Surg 1995;29:211-219
2. Tanaka M, Nakakita N, Kuroyanagi Y. Allogeneic cultured dermal substitute composed of spongy collagen containing fibroblasts: evaluation in animal test. J Biomater Sci Polym Ed 1999;10:433-453
3. Yamada N, Uchinuma N, Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand J Plast Reconstr Surg 1999;33:147-154
4. Kuroyanagi Y, Yamada N. Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25:180-186
5. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: fundamental evaluation. J Biomater Sci Polymer Ed 2003;14:625-641
6. Kubo K, Kuroyanagi Y. Characterization of cultured dermal substitute composed of spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organs 2003;6:138-144
7. Kubo K, Kuroyanagi Y. Effects of vascular endothelial growth factor released from cultured dermal substitute on proliferation of vascular endothelial cells in vitro. J Artif Organs 2003;6:267-272
8. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts: cryopreservation. Artif Organs 2004;28:182-188
9. Kubo K, Kuroyanagi Y. The possibility of long-term cryopreservation of cultured dermal substitute. Artif Organs 2005;29:800-805
10. Kubo K, Kuroyanagi Y. A study of cytokines released form fibroblasts in culture dermal substitute. Artif Organs 2005;29:845-849
11. Kuroyanagi Y, Kubo K, Matsui H, Kim H-J, Numari S, Mabuchi Y, Kagawa S. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004;28:13-21
12. Culp LA, Murray BA, Rollins BJ. Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct 1979;11:401-427
13. Benedetti L, Cortivo R, Berti T, Berti A, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats. Biomaterials 1993;14:1154-1160
14. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagenderived peptides. Proc Natl Acad Sci USA 1978;75:871-875
15. Clark RA. Continuing medical education: cutaneous tissue repair - basic biologic considerations I. J Am Acad Dermatol 1985;13:701-725
16. Phillips TJ. Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol 1994;102(6):38S-41S
17. Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Artif Organs 2004;28:444-450
18. Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, Ueda K, Kubo K, Kuroyanagi Y, Furukawa F. Digital gangrene associated with idiopathic hypereosinophilia; treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004;14:168-171
19. Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, Urabe K, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y, Furue M. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol 2004;14:172-176
20. Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in three patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004;50:803-804
21. Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, Kubo K, Kuroyanagi Y. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports. J Dermatol 2005;32:715-720
22. Yonezawa M, Tanizaki H, Inoguchi N, Ishida M, Katoh M, Tachibana T, Miyachi Y, Kubo K, Kuroyanagi Y. Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. Int J Dermatol 2007;46(1):36-42
23. Nishimoto J, Amoh Y, Tanabe K, Niiyama N, Katsuoka K, Kuroyanagi Y. Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: treatment with allogeneic cultured dermal substitute. Eur J Dermatol 2007:17(4):350-351
24. Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Mizuno Y, Haruna K, Ikeda S, Kuroyanagi Y, Ogawa H. Intractable venous leg ulcer treated successfully with allogeneic cultured dermal substitute. Scand J Plast Reconstr Surg Hand Surg 2007;19:1-3